Oclorus™Spermidine Supplement
  • Home
  • Fisetin
  • Dasatinib-Quercetin
  • Navitoclax (ABT-263)
  • UBX1325
  • More
    • Home
    • Fisetin
    • Dasatinib-Quercetin
    • Navitoclax (ABT-263)
    • UBX1325
Oclorus™Spermidine Supplement
  • Home
  • Fisetin
  • Dasatinib-Quercetin
  • Navitoclax (ABT-263)
  • UBX1325

UBX1325–Bcl-xL Inhibitor for Bulk Orders

<img src="ubx1325.jpg" alt="Mitora™ UBX1325 Bcl-xL inhibitor for research use">

High-Purity UBX1325 – Bcl-xL Inhibitor Supplier for Labs & Distributors

Discover Mitora™UBX1325–a high-purity Bcl-xL inhibitor optimized for senolytic studies, apoptosis research, and preclinical applications. Designed for research institutions, laboratories, and B2B distributors, our UBX1325 delivers consistent quality and reliable results for cutting-edge cellular biology experiments. 

Technical Details

  • Chemical Name: UBX1325
     
  • CAS Number: 1646956-92-2
     
  • Appearance: Off-white to pale-yellow crystalline powder
     
  • Purity: ≥99%
     
  • Storage: Keep in a cool, dry environment, protected from light

Applications

  • Cellular Senescence Research–Study targeted removal of senescent cells.
     
  • Apoptosis Studies–Investigate Bcl-xL mediated pathways.
     
  • Drug Discovery & Preclinical Research–Evaluate potential senolytic therapies.
     
  • B2B Research Supply–Bulk quantities for distributors and laboratories worldwide.

Why Choose UBX1325 from Mitora™?

  • Premium Research-Grade Quality: ≥99% purity ensures high reproducibility in senescence and apoptosis assays.
     
  • Powerful Senolytic Action: Selectively targets Bcl-xL proteins, promoting senescent cell clearance and experimental accuracy.
     
  • Flexible Bulk Supply: Available for B2B distribution, academic labs, and biotech research programs.
     
  • Verified Quality: Every batch includes a Certificate of Analysis (COA) for purity and identity confirmation.
     
  • Global Support: Optimized for secure packaging and international shipping, meeting B2B procurement needs.


Copyright©2023 Mitora™

Powered by Mitora™

  • Cardiac glycosides
  • Navitoclax-ABT-263
  • Ouabain–Cardiac Glycoside
  • Piperlongumine
  • 17-DMAG–HSP90 Inhibitor
  • Quality & Technology
  • About Us
  • Terms of Service
  • Privacy Policy
  • FAQ
  • Contact Us
  • Senolytic Compound News
  • Equal Opportunity
  • Legal Disclaimer–Mitora™
  • Health & Safety–Mitora™
  • Accessibility Statement

This website uses cookies.

We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.

DeclineAccept